Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets is a research paper published in Nature Microbiology (2020). On theSindex it has a DataRank of 11.5. It has been cited 412 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.904
From this paper's citation signal
Citation Network Contribution
10.6
From 100 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI071002
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Grant: AI141222
NIAID NIH HHS
Grant: R01 AI071002
NIAID NIH HHS
Grant: R01 AI141222
NIAID NIH HHS
Grant: R01 AI153400
National Institutes of Health
Grant: 5R01AI071002-10
Developing Myxovirus Inhibitors with Expanded Pathogen Target Range
National Institutes of Health
Grant: 5R01AI141222-05
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
FWCI
8.47
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals